References
1
Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, et al. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience. J Clin Oncol 2009; 27: 2668-76.
2
Gunning K, Pippitt K, Kiraly B, Sayler M. Pediculosis and scabies: treatment update. Am Fam Physician 2012; 86: 535-41.
3
Astudillo L, Loche F, Reynish W, Rigal-Huguet F, Lamant L, Pris J. Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia. Ann Hematol 2002; 81: 111-4.
4
Morio K, Mizuki M, Sozu T, Uejima E. Risk factors for cytarabine-induced cutaneous toxicity in patients with haematological malignancies. Chemotherapy 2014; 60: 168-73.
5
Haidari W, Strowd LC. Clinical characterization of leukemia cutis presentation. Cutis 2019; 104: 326-30.
6
Trendelenburg M, Büchner S, Passweg J, Rätz Bravo AR, Gratwohl A. Disseminated scabies evolving in a patient undergoing induction chemotherapy for acute myeloblastic leukaemia. Ann Hematol 2001; 80: 116-8.
